Clinical trial
Alterations in the Transcription, Metabolism and Gut Microbiome in Young Adults With Coronary Syndrome Severity
NCT04864457 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alterations in the Transcription, Metabolism and Gut Microbiome in Young Adults With Coronary Syndrome Severity
- Lead sponsor
- Shenzhen People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2020
- Completion date
- July 31, 2021
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary syndrome